Form 4: Friedman Industries Director Max Reichenthal Acquires 2,000 Shares
SEC Form 4 Filing
Director Max Reichenthal of Friedman Industries Inc. purchased 2,000 shares of common stock at $13.72 per share on November 20, 2024.
Summary
- Max Reichenthal, a director at Friedman Industries Inc., acquired 2,000 shares of the company's common stock.
- The transaction occurred on November 20, 2024.
- The purchase price was $13.72 per share.
- Following the transaction, Reichenthal directly owns 32,761 shares of Friedman Industries Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive as a director buying shares can be seen as a sign of confidence, but it's a routine transaction.
Positives
- The purchase of shares by a director can be seen as a positive sign of confidence in the company's future prospects.
Industry Context
Insider trading activity is closely monitored by regulators and investors as it can provide insights into management's view of the company's prospects.
Comparison to Industry Standards
- It is common for directors and officers to buy or sell shares of their company, and these transactions are required to be disclosed to the SEC.
- The size of this transaction is relatively small compared to some insider trades, but it is still a notable event.
Stakeholder Impact
- The share purchase may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 11/20/2024 | Date of the share purchase transaction. |
| 11/22/2024 | Date of signature on the SEC Form 4 filing. |
Keywords
Friedman Industries, insider trading, share purchase, director, Max Reichenthal, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.